medical radiology
Carney’s Canada Investment Summit Puts Canada’s Ability to Build (and Finance) on Trial
“As someone who has worked on the front lines of the critical minerals industry for many years, I…
- September 2026
- August 2026
- July 2026
- June 2026
- May 2026
- April 2026
- March 2026
- February 2026
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
-
Voyageur Pharmaceuticals Secures Iodine Collaboration with Bayer
In a sector more accustomed to drill results than drug pipelines, Voyageur Pharmaceuticals Ltd. (TSXV: VM) has taken…
No CommentsInvestorNews
-
InvestorTalk Alert: Brent Willis from Voyageur Pharmaceuticals Ltd. to host on Thursday, February 6, 2025
Investor.News is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Thursday, February 6th, at 9 AM EST,…
No CommentsInvestorNews
-
Voyageur Pharmaceuticals’ Brent Willis on the Indispensable Role of Barium
January 27, 2025 — In an enlightening interview on Investor.News, Brent Willis, President, CEO, and Director of Voyageur Pharmaceuticals…
No CommentsInvestorNews
-
Voyageur Pharmaceuticals’ Brent Willis on Becoming First Domestically Produced Radiology Drug Company
January 24, 2025 — In a recent interview with Investor.News host Tracy Hughes, Brent Willis, President, CEO, and Director…
No CommentsInvestorNews
-
Voyageur’s Partnership with Rain Cage Offers the Promise of Transforming Diagnostic Imaging and Healthcare Solutions
Testing to Begin of Radiology Endohedral Fullerenes, a Milestone in Nanotechnology & Drug Development Voyageur Pharmaceuticals Ltd. (TSXV: VM)…
No CommentsInvestorNews
-
Offering freedom from China on Foreign Medical Imaging Supplies, Voyageur Pharmaceuticals announces another key milestone
Barium and iodine-based radiographic contrast media (RCM) are types of RCM used in diagnostic imaging. Both work by…
No CommentsInvestorNews
-
Voyageur’s quest to become the only fully integrated company in the radiographic contrast media field accelerates timeline with design of a carbon neutral pharmaceutical plant
Did you know that when you go to the doctor and require an X-Ray or scan in many…
1 CommentTracy Hughes
-
Voyageur Pharmaceuticals completes FDA submission milestone for first barium contrast product license application
Radiographic contrast media are substances used in diagnostic imaging tests such as ultrasound, X-rays, CT scans and MRI…
No CommentsInvestorNews
-
Brent Willis of Voyageur Pharmaceuticals discusses the high IRR and NPV in its recent PEA
In a recent InvestorIntel interview, Tracy Weslosky spoke with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd. (TSXV:…
3 CommentsInvestorNews
-
Voyageur Pharmaceuticals’ Brent Willis on creating the first vertically integrated medical radiological contrast media supplier in NA
In a recent InvestorIntel interview, Tracy Weslosky spoke with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd. (TSXV:…
No CommentsInvestorNews
InvestorNews Member News
-
Critical Minerals Americas Inc. Appoints Ken Bradley as Executive Vice President External Relations and Chief Sustainability Officer
-
Antimony Resources Corp. (ATMY) (ATMYF) (K8J0) Reports High-Grade Antimony (Sb) Assays – Drills 27.3% Sb Over 0.3 Meters (m) Within a Zone of 2.28% Sb Over a Length of 9.12 m
-
Drill Program Successfully Completed at Horse Heaven Antimony-Tungsten-Gold-Silver Project – Idaho USA
-
American Rare Earths Appoints Dr. Sanja Miskovic as Chief Technical Advisor
-
Koppamurra Pilot Plant Advances to Mixed Rare Earth Hydroxide Production
